Regulation of macrophage tumor necrosis factor production by prostaglandin E2.
We have studied the role of prostaglandin E2 on the modulation of tumor necrosis factor by immunologically elicited and lipopolysaccharide treated murine macrophages. Indomethacin, a potent inhibitor of prostaglandin E2 production, caused a dose dependent augmentation of lipopolysaccharide induced tumor necrosis factor production (2-3 fold at 10(-7) molar). Tumor necrosis factor was released into the extracellular environment and no activity was found to be associated with membrane or cytosolic fractions. Prostaglandin E2 added to the lipopolysaccharide treated cultures suppressed tumor necrosis factor in a dose dependent manner. In these studies, 10(-7) molar PGE2 reduced tumor necrosis factor production to basal levels. These data suggest that PGE2 may be a potent autoregulatory factor that dramatically influences tumor necrosis factor production.
Kunkel
S L
SL
Wiggins
R C
RC
Chensue
S W
SW
Larrick
J
J
D000818:Animals; D002478:Cells, Cultured; D015232:Dinoprostone; D005246:Feedback; D005260:Female; D006023:Glycoproteins / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000502:physiology*; D051379:Mice; D011458:Prostaglandins E / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha; D015054:Zymosan / Q000276:immunology
D006023:Glycoproteins; D008070:Lipopolysaccharides; D011458:Prostaglandins E; D014409:Tumor Necrosis Factor-alpha; D015054:Zymosan; D015232:Dinoprostone; D007213:Indomethacin